Category: Insights
There are more than 7,000 diseases that are considered “rare,” that is, affecting fewer than 200,000 Americans. Yet around one in ten Americans lives with at least one of these…
The post Orphan Drug Patents: Concerns Raised by Payers and Policy Makers …
Like this:
Like Loading...
A few years ago, there was much talk of the “patent cliff” facing blockbuster drugs like Lipitor and other huge name-brand drugs. The “patent cliff” may have spelled the end…
The post Why Generic Drug Makers May Benefit from 505(b)(2) Approval appeared…
Like this:
Like Loading...
October 22, 2018 Comments Off on Patenting human genes: Chinese academic articles’ portrayal of gene patents Posted in: General Biotechnology, Insights This article was originally published by Li Du in BMC Medical Ethics 2018 19:29 under a creative commons license. Abstract Background The patenting of human genes has been the subject…
The post Patenting human genes: Chinese academic articles’ portraya…
Like this:
Like Loading...
October 15, 2018 Comments Off on The 505(b)(2) Drug Patent Approval Process: Uses and Potential Advantages Posted in: General Biotechnology, Insights Drug development is one of the world’s most high-risk / high-reward industries, with the vast majority of drugs created never making it to market. Of those that do make it…
The post The 505(b)(2) Drug Patent Approval Process: Uses and Potential Advanta…
Like this:
Like Loading...
Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries This book describes the way that pharmaceutical projects and programs are currently managed, and offers views from many highly…
The post Pharmaceutical Portfo…
Like this:
Like Loading...
Artificial intelligence (AI) is the development within computer systems of the ability to perform tasks that have traditionally required human intelligence. Examples of AI applications include visual perception, speech recognition,…
The post How Artifi…
Like this:
Like Loading...
This paper was originally published by Dibyendu Dana, Satishkumar V. Gadhiya, Luce G. St. Surin, David Li, Farha Naaz, Quaisar Ali, Latha Paka, Michael A. Yamin, Mahesh Narayan, Itzhak D. Goldberg…
The post Deep Learning in Drug Discovery and Medicine …
Like this:
Like Loading...
October 1, 2018 Comments Off on Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection Posted in: General Biotechnology, Insights This article was originally published by Christopher M. Holman in Intellectual Property Watch under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (http://creativecommons.org/licenses/by-nc-sa/4.0/). Despite the impor…
Like this:
Like Loading...
The US pharmaceutical market, together with those of Canada and Mexico, make more than half the global pharmaceutical. The US alone is the world’s largest and it represents 45 percent of…
The post FDA Approval of New Drugs One of Many Goals for Drug Ma…
Like this:
Like Loading...
September 17, 2018 Comments Off on Evidence of insufficient quality of reporting in patent landscapes in the life sciences Posted in: General Biotechnology, Insights This article was originally published by James A Smith, Zeeshaan Arshad, Hannah Thomas, Andrew J Carr & David A Brindley in Nature Biotechnology v35, pp 210–214 (2017) under a creative…
The post Evidence of insufficient quality of reporting in patent l…
Like this:
Like Loading...